|
US7157555B1
(en)
*
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
AU2003301195B2
(en)
|
2002-12-20 |
2010-01-07 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
SI1624891T2
(sl)
|
2003-05-06 |
2013-09-30 |
Biogen Idec Hemophilia Inc. |
Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
DK2520654T3
(en)
|
2003-08-26 |
2017-05-01 |
Univ Colorado Regents |
Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections
|
|
BRPI0406605B8
(pt)
*
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
KR101135244B1
(ko)
*
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
|
US8263084B2
(en)
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
PL1759001T3
(pl)
*
|
2004-04-21 |
2011-09-30 |
Alexion Pharma Inc |
Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
EP1773400A2
(en)
*
|
2004-07-08 |
2007-04-18 |
Amgen Inc. |
Therapeutic peptides
|
|
CA2580796C
(en)
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
KR100594607B1
(ko)
*
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
CA2592015A1
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
CA2597346A1
(en)
*
|
2005-02-14 |
2006-08-17 |
Apollo Life Sciences Limited |
A molecule and chimeric molecules thereof
|
|
KR100754667B1
(ko)
*
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
AU2006272555B2
(en)
*
|
2005-07-25 |
2012-03-08 |
Aptevo Research And Development Llc |
B-cell reduction using CD37-specific and CD20-specific binding molecules
|
|
US8008453B2
(en)
*
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
KR100824505B1
(ko)
*
|
2005-08-16 |
2008-04-22 |
한미약품 주식회사 |
개시 메티오닌 잔기가 제거된 면역글로불린 Ｆｃ 영역의대량 생산방법
|
|
CA2619771C
(en)
*
|
2005-08-16 |
2012-05-22 |
Hanmi Pharmaceutical Co., Ltd. |
A method for the mass production of immunoglobulin fc region deleted initial methionine residues
|
|
CN101534865A
(zh)
*
|
2005-10-19 |
2009-09-16 |
Ibc药品公司 |
生物活性装配体的制备方法及其用途
|
|
WO2007048127A2
(en)
*
|
2005-10-20 |
2007-04-26 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
AR056142A1
(es)
*
|
2005-10-21 |
2007-09-19 |
Amgen Inc |
Metodos para generar el anticuerpo igg monovalente
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
KR101866623B1
(ko)
|
2005-11-28 |
2018-07-04 |
젠맵 에이/에스 |
재조합 １가 항체 및 그의 제조 방법
|
|
US20070149458A1
(en)
*
|
2005-12-06 |
2007-06-28 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
CN100475270C
(zh)
|
2006-01-20 |
2009-04-08 |
清华大学 |
一种治疗肿瘤的药物及其应用
|
|
CN101002945B
(zh)
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
|
CN105837690A
(zh)
*
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
JP2010501623A
(ja)
*
|
2006-08-28 |
2010-01-21 |
アレス トレーディング ソシエテ アノニム |
Ｆｃ含有タンパク質の精製法
|
|
US20140147441A1
(en)
*
|
2006-09-12 |
2014-05-29 |
The General Hospital Corporation |
Compositions containing alpha-1-antitrypsin and methods for use
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
US20080181903A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
JP2008169195A
(ja)
*
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
|
US20080238882A1
(en)
*
|
2007-02-21 |
2008-10-02 |
Ramesh Sivarajan |
Symmetric touch screen system with carbon nanotube-based transparent conductive electrode pairs
|
|
TW201718635A
(zh)
|
2007-03-06 |
2017-06-01 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
US9610327B2
(en)
|
2007-03-06 |
2017-04-04 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
MX2009012609A
(es)
|
2007-05-22 |
2009-12-07 |
Amgen Inc |
Composiciones y metodos para producir proteinas de fusion bioactivas.
|
|
CN101687933B
(zh)
*
|
2007-05-30 |
2015-11-25 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
|
EP2615175B1
(en)
*
|
2007-05-31 |
2018-08-08 |
Genmab A/S |
Monovalent human antibodies
|
|
SI2185589T1
(sl)
|
2007-06-01 |
2016-04-29 |
University Of Maryland Baltimore |
Vezavna sredstva za Fc receptor konstantne regije imunoglobulina
|
|
US20100310561A1
(en)
*
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
CN101842389A
(zh)
*
|
2007-06-12 |
2010-09-22 |
惠氏有限责任公司 |
抗cd20治疗组合物和方法
|
|
WO2009023386A2
(en)
*
|
2007-07-06 |
2009-02-19 |
Trubion Pharmaceuticals, Inc. |
Binding peptides having a c-terminally disposed specific binding domain
|
|
US8492347B2
(en)
*
|
2007-10-17 |
2013-07-23 |
The Regents Of The University Of California |
Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus
|
|
CN101918027A
(zh)
*
|
2007-11-02 |
2010-12-15 |
森托科尔奥索生物科技公司 |
半合成GLP-1肽-Fc融合构造、方法及其用途
|
|
NZ603059A
(en)
*
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
EP2300501B1
(en)
|
2008-07-23 |
2014-08-20 |
Hanmi Science Co., Ltd. |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
|
RU2457856C2
(ru)
*
|
2008-08-05 |
2012-08-10 |
Виктор Владимирович Чалов |
Композиция, обладающая противовирусным и антимикробным действием, для перорального применения
|
|
CA2732949C
(en)
*
|
2008-08-07 |
2016-12-20 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
KR20130133103A
(ko)
*
|
2008-08-07 |
2013-12-05 |
입센 파마 에스.에이.에스 |
Ｎ-말단이 변형된 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드(ｇｉｐ)의 유사체
|
|
ES2574835T3
(es)
|
2008-08-07 |
2016-06-22 |
Ipsen Pharma S.A.S. |
Análogos del polipéptido insulinotrópico dependiente de glucosa
|
|
US20110206633A1
(en)
*
|
2008-09-19 |
2011-08-25 |
Nektar Therapectics |
Polymer conjugates of cd-np peptides
|
|
EP2350118B1
(en)
*
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
CA2742064A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Amgen Inc. |
Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
|
|
PE20150680A1
(es)
|
2008-11-26 |
2015-05-16 |
Amgen Inc |
Variantes de polipeptidos receptores de activina iib y aplicaciones de estos
|
|
WO2010065578A2
(en)
*
|
2008-12-04 |
2010-06-10 |
Leukosight Inc. |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
|
|
US20100158893A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Baxter International Inc. |
Systems and methods for obtaining immunoglobulin from blood
|
|
AR075029A1
(es)
*
|
2009-01-19 |
2011-03-02 |
Hanmi Pharm Ind Co Ltd |
Metodo para producir una proteina o un peptido fisiologicamente activo usando un fragmento de inmunoglobulina
|
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
EP2401378B1
(en)
|
2009-02-25 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
|
|
EP2411024A4
(en)
*
|
2009-03-24 |
2013-02-27 |
Bayer Healthcare Llc |
Variants of factor viii and associated methods of use
|
|
CN102439044B
(zh)
*
|
2009-04-22 |
2014-08-13 |
阿特根公司 |
通过体内持续释放维持的体内半衰期增加的融合蛋白质或融合肽以及使用所述融合蛋白质或融合肽增加体内半衰期的方法
|
|
US20120219538A1
(en)
*
|
2009-11-02 |
2012-08-30 |
Therapeomic Ag |
Stabilized protein formulations and use thereof
|
|
US9629920B2
(en)
|
2009-12-18 |
2017-04-25 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
PT2525787T
(pt)
|
2010-01-19 |
2017-12-18 |
Hanmi Science Co Ltd |
Formulações líquidas para conjugado de g-csf de longa ação
|
|
RU2682720C2
(ru)
*
|
2010-01-19 |
2019-03-21 |
Ханми Сайенс Ко., Лтд. |
Жидкие составы для конъюгата эритропоэтина длительного действия
|
|
WO2011093470A1
(ja)
*
|
2010-01-28 |
2011-08-04 |
協和発酵キリン株式会社 |
Bone morphogenetic protein receptor 1B(BMPR1B)細胞外ドメイン又はその変異体を含む蛋白質を含有する骨疾患治療用医薬組成物
|
|
BR112012020882A2
(pt)
|
2010-02-24 |
2015-11-03 |
Merck Sharp & Dohme |
métodos para produzir uma glicoproteína heteróloga e para produzir uma composição de glicoproteína, célula hospedeira, composição de glicoproteína, e, uso da pichia pastoris recombinante.
|
|
WO2011110515A1
(en)
*
|
2010-03-08 |
2011-09-15 |
Affibody Ab |
Immunoglobulin g fc region binding polypeptide
|
|
AR081066A1
(es)
*
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
|
AR080993A1
(es)
*
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
|
AR081755A1
(es)
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
|
CN103153344A
(zh)
|
2010-04-30 |
2013-06-12 |
阿莱克森国际制药有限公司 |
用于治疗基质矿化障碍的方法、组合物、和试剂盒
|
|
US8691771B2
(en)
|
2010-05-21 |
2014-04-08 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins for tissue repair
|
|
KR101330868B1
(ko)
*
|
2010-06-08 |
2013-11-18 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 인슐린 유도체 약물 결합체
|
|
KR20120002129A
(ko)
*
|
2010-06-30 |
2012-01-05 |
한미홀딩스 주식회사 |
면역글로불린 단편을 이용한 제７인자（Ｆａｃｔｏｒ Ⅶａ）약물 결합체
|
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
KR101382593B1
(ko)
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
WO2012016073A2
(en)
|
2010-07-28 |
2012-02-02 |
Gliknik Inc. |
Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
KR101333958B1
(ko)
*
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
KR101303388B1
(ko)
*
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
EP2655413B1
(en)
|
2010-12-23 |
2019-01-16 |
F.Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
JP6055779B2
(ja)
|
2010-12-27 |
2016-12-27 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
ナトリウム利尿ペプチドを含む組成物およびその使用方法
|
|
EP2663647A4
(en)
|
2011-01-14 |
2015-08-19 |
Redwood Bioscience Inc |
POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD
|
|
CN102309765B
(zh)
*
|
2011-02-28 |
2013-10-16 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段作为载体的长效抗凝多肽及其制备方法
|
|
JP5977814B2
(ja)
|
2011-04-08 |
2016-08-24 |
アムジエン・インコーポレーテツド |
増殖分化因子１５（ｇｄｆ−１５）を使用して代謝障害を治療または改善する方法
|
|
UA113626C2
(xx)
*
|
2011-06-02 |
2017-02-27 |
|
Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
|
|
CN102807619B
(zh)
*
|
2011-06-03 |
2016-08-03 |
北京韩美药品有限公司 |
含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
|
|
HRP20181591T1
(hr)
|
2011-06-10 |
2018-11-30 |
Hanmi Science Co., Ltd. |
Novi derivati oksintomodulina i farmaceutski pripravci za liječenje pretilosti koji ih sadrže
|
|
TWI601744B
(zh)
|
2011-06-17 |
2017-10-11 |
韓美科學股份有限公司 |
包含調酸素與免疫球蛋白片段之複合物及其用途
|
|
EP3628327A1
(en)
*
|
2011-06-24 |
2020-04-01 |
The Regents of the University of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
SMT201900520T1
(it)
*
|
2011-06-28 |
2019-11-13 |
Inhibrx Lp |
Polipeptidi di fusione serpinici e relativi metodi d'uso
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
RU2639526C2
(ru)
*
|
2011-06-28 |
2017-12-21 |
ИНХИБРКС ЭлЭлСи |
Слитые полипептиды, содержащие домен wap, и способы их применения
|
|
BR112014005091A2
(pt)
*
|
2011-09-05 |
2017-06-13 |
Beijing Hanmi Pharmaceutical Co Ltd |
composição farmacêutica para o tratamento do câncer compreendendo conjugado de interferon alfa
|
|
US9458214B2
(en)
|
2011-09-26 |
2016-10-04 |
Novartis Ag |
Dual function fibroblast growth factor 21 proteins
|
|
TWI565715B
(zh)
*
|
2011-10-06 |
2017-01-11 |
韓美科學股份有限公司 |
凝血因子VII及VIIa之衍生物、接合物及含該接合物之複合物與其用途
|
|
JP6158090B2
(ja)
*
|
2011-10-31 |
2017-07-05 |
ダニエル・ジェイ・カポン |
非ペプチドヒンジ部含有フレキシブル抗体様分子
|
|
KR20130049671A
(ko)
*
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
CN103172745A
(zh)
*
|
2011-12-21 |
2013-06-26 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段的长效人内皮抑素
|
|
KR101895047B1
(ko)
*
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
KR102041412B1
(ko)
*
|
2011-12-30 |
2019-11-11 |
한미사이언스 주식회사 |
면역글로불린 Ｆｃ 단편 유도체
|
|
US20140050720A1
(en)
|
2012-01-09 |
2014-02-20 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
|
EP2802601B1
(en)
|
2012-01-09 |
2019-11-13 |
The Scripps Research Institute |
Humanized antibodies with ultralong cdr3s
|
|
KR20140137347A
(ko)
|
2012-01-10 |
2014-12-02 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
|
KR20140125803A
(ko)
|
2012-01-26 |
2014-10-29 |
암젠 인크 |
성장 분화 인자 15(gdf-15) 폴리펩타이드들
|
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
CN104254542A
(zh)
|
2012-03-09 |
2014-12-31 |
瑞士杰特贝林生物制品有限公司 |
包含分泌-样免疫球蛋白的组合物
|
|
US10064951B2
(en)
|
2012-03-30 |
2018-09-04 |
Hanmi Science Co., Ltd. |
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
|
|
JP5855239B2
(ja)
*
|
2012-04-23 |
2016-02-09 |
株式会社Ｎｒｌファーマ |
ラクトフェリン融合タンパク質及びその製造方法
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
US9738724B2
(en)
|
2012-06-08 |
2017-08-22 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(en)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
ES2597228T3
(es)
|
2012-06-27 |
2017-01-17 |
F. Hoffmann-La Roche Ag |
Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
|
|
KR20150030744A
(ko)
*
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
|
|
AR092862A1
(es)
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
|
US10441665B2
(en)
|
2012-07-25 |
2019-10-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of long acting insulinotropic peptide conjugate
|
|
AR094821A1
(es)
*
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
|
AR091902A1
(es)
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
|
KR20150058236A
(ko)
|
2012-08-20 |
2015-05-28 |
글리크닉 인코포레이티드 |
항원 결합 및 다가 fc 감마 수용체 결합 활성을 가진 분자
|
|
SI2890402T1
(sl)
|
2012-08-31 |
2019-07-31 |
Sutro Biopharma, Inc. |
Modificirane aminokisline vsebujoče acido skupino
|
|
KR20150052085A
(ko)
|
2012-09-14 |
2015-05-13 |
에프. 호프만-라 로슈 아게 |
2개 이상의 상이한 단위를 포함하는 분자의 제조 및 선별 방법, 및 이의 용도
|
|
WO2014043523A1
(en)
|
2012-09-14 |
2014-03-20 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
|
|
KR101993393B1
(ko)
*
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
|
EA039082B1
(ru)
|
2012-11-06 |
2021-12-01 |
Ханми Фарм. Ко., Лтд. |
Жидкая композиция белкового конъюгата, содержащего оксинтомодулин и фрагмент иммуноглобулина
|
|
EP2943512A4
(en)
*
|
2013-01-11 |
2016-06-01 |
California Inst Biomedical Res |
BOVINE FUSION ANTIBODY
|
|
CN103217489B
(zh)
*
|
2013-01-15 |
2016-03-09 |
珠海市丽珠单抗生物技术有限公司 |
一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
|
|
KR102073748B1
(ko)
*
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
|
KR20150136061A
(ko)
|
2013-02-01 |
2015-12-04 |
산타 마리아 바이오테라퓨틱스, 인코포레이티드 |
대상에 항-액티빈-a 화합물의 투여
|
|
BR112015019778A2
(pt)
|
2013-02-22 |
2017-08-22 |
Zoetis Services Llc |
Administração in ovo de fatores de crescimento para o aperfeiçoamento de desempenho de ave doméstica
|
|
SG11201506937RA
(en)
*
|
2013-03-05 |
2015-10-29 |
Hanmi Pharm Ind Co Ltd |
Improved preparation method for high-yield production of physiologically active polypeptide conjugate
|
|
JP2016511275A
(ja)
|
2013-03-11 |
2016-04-14 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
成長ホルモン化合物
|
|
US20140271641A1
(en)
*
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
|
SG11201505926VA
(en)
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
|
CN114717206A
(zh)
|
2013-03-15 |
2022-07-08 |
Atyr 医药公司 |
组氨酰-trna合成酶-fc缀合物
|
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
|
WO2015006555A2
(en)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
|
AR096891A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
|
JP6687520B2
(ja)
|
2013-07-18 |
2020-04-22 |
トーラス バイオサイエンシズ リミテッド ライアビリティ カンパニー |
極めて長い相補性決定領域を有するヒト化抗体
|
|
LT3027642T
(lt)
|
2013-07-31 |
2020-10-12 |
Amgen Inc. |
Augimo ir diferenciacijos faktoriaus 15(gdf-15) konstruktai
|
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
|
ES2819217T3
(es)
|
2013-09-08 |
2021-04-15 |
Kodiak Sciences Inc |
Conjugados de polímeros iónicos dipolares y factor VIII
|
|
DK3043810T3
(da)
|
2013-09-09 |
2020-01-27 |
Canimguide Therapeutics Ab |
Immunsystemsmodulatorer
|
|
CN105848645A
(zh)
|
2013-09-27 |
2016-08-10 |
韩美药品株式会社 |
持续型人生长激素制剂
|
|
WO2015047890A1
(en)
*
|
2013-09-30 |
2015-04-02 |
3M Innovative Properties Company |
Fibers and wipes with epoxidized fatty ester disposed thereon, and methods
|
|
EP3068797B1
(en)
|
2013-11-11 |
2020-01-08 |
Wake Forest University Health Sciences |
Constructs for multi-valent targeting of tumors
|
|
MY186251A
(en)
|
2014-01-20 |
2021-06-30 |
Hanmi Pharm Ind Co Ltd |
Long-acting insulin and use thereof
|
|
US10421796B2
(en)
*
|
2014-01-21 |
2019-09-24 |
Gray D Shaw |
Variants of IgG Fc with limited amine groups
|
|
KR102385120B1
(ko)
*
|
2014-03-31 |
2022-04-12 |
한미약품 주식회사 |
면역글로불린 Fc 단편 결합을 이용한 단백질 및 펩타이드의 용해도를 개선시키는 방법
|
|
ES2719584T3
(es)
*
|
2014-04-11 |
2019-07-11 |
Medimmune Llc |
Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína
|
|
EP3137495A4
(en)
*
|
2014-04-28 |
2017-11-15 |
The National Institute for Biotechnology in the Negev, Ltd. |
Variants of dr3 and use thereof
|
|
KR20150133576A
(ko)
*
|
2014-05-20 |
2015-11-30 |
삼성전자주식회사 |
화학적 개질된 표적화 단백질 및 그의 이용
|
|
AR100639A1
(es)
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
|
TWI684458B
(zh)
|
2014-05-30 |
2020-02-11 |
南韓商韓美藥品股份有限公司 |
包含胰島素及ｇｌｐ-１/昇糖素雙重促效劑之治療糖尿病之組成物
|
|
AU2015279321B2
(en)
*
|
2014-06-27 |
2021-03-04 |
Innate Pharma, S.A. |
Multispecific antigen binding proteins
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
WO2015200905A2
(en)
|
2014-06-28 |
2015-12-30 |
Oligasis, Llc |
Dual pdgf/vegf antagonists
|
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
SG10202102467RA
(en)
|
2014-07-24 |
2021-04-29 |
Genentech Inc |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
|
TWI772252B
(zh)
|
2014-09-16 |
2022-08-01 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
EP3207128B1
(en)
*
|
2014-10-17 |
2022-07-27 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
|
JP6787894B2
(ja)
|
2014-12-05 |
2020-11-18 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
組換えアルカリホスファターゼを用いた発作の処置
|
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
|
KR102291020B1
(ko)
|
2014-12-30 |
2021-08-20 |
한미약품 주식회사 |
안정성이 증가된 글루카곤 유도체
|
|
CA2973883A1
(en)
|
2015-01-28 |
2016-08-04 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
|
WO2016144650A1
(en)
|
2015-03-06 |
2016-09-15 |
Canimguide Therapeutics Ab |
Immune system modulators and compositions
|
|
CN113683708A
(zh)
*
|
2015-04-06 |
2021-11-23 |
阿塞勒隆制药公司 |
单臂i型和ii型受体融合蛋白和其用途
|
|
CA2983440C
(en)
|
2015-04-22 |
2024-03-12 |
Alivegen Usa Inc. |
Novel hybrid actriib ligand trap proteins for treating muscle wasting diseases
|
|
EP3288965B1
(en)
*
|
2015-04-29 |
2019-06-26 |
Mediolanum Farmaceutici S.p.A. |
A soluble chimeric interleukin-10 receptor and therapeutic use thereof
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
EP3303380B1
(en)
|
2015-06-02 |
2020-01-15 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
AU2016274890B2
(en)
*
|
2015-06-12 |
2022-02-10 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
AU2016284871B2
(en)
|
2015-06-23 |
2022-09-29 |
Innate Pharma |
Multispecific NK engager proteins
|
|
FI3322437T3
(fi)
|
2015-06-30 |
2024-02-20 |
Hanmi Pharmaceutical Co Ltd |
Glukagonijohdannainen ja sen pitkävaikutteisen konjugaatin käsittävä koostumus
|
|
TW201718022A
(zh)
|
2015-07-24 |
2017-06-01 |
韓美藥品股份有限公司 |
製備生理活性多肽接合物的方法
|
|
IL309260B2
(en)
|
2015-07-24 |
2025-01-01 |
Gliknik Inc |
Fusion proteins of human protein fragments to create ordered multimeric immunoglobulin FC preparations with enhanced complement binding
|
|
JP6993961B2
(ja)
|
2015-08-17 |
2022-01-14 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼの製造
|
|
UY36870A
(es)
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
|
HK1251480A1
(zh)
|
2015-09-21 |
2019-02-01 |
Aptevo Research And Development Llc |
Cd3结合多肽
|
|
CN108136276B
(zh)
*
|
2015-09-24 |
2023-02-28 |
韩美药品株式会社 |
通过使用免疫球蛋白片段的特异性位点进行连接的蛋白质复合物
|
|
TW201718629A
(zh)
*
|
2015-09-25 |
2017-06-01 |
韓美藥品股份有限公司 |
包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物
|
|
EP3355904A4
(en)
|
2015-09-28 |
2019-06-12 |
Alexion Pharmaceuticals, Inc. |
IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
|
|
SG10201913573UA
(en)
|
2015-10-01 |
2020-03-30 |
Heat Biologics Inc |
Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
|
|
WO2017055582A1
(en)
|
2015-10-01 |
2017-04-06 |
Novo Nordisk A/S |
Protein conjugates
|
|
CA3000742A1
(en)
|
2015-10-02 |
2017-04-06 |
Silver Creek Pharmaceuticals, Inc. |
Bi-specific therapeutic proteins for tissue repair
|
|
US20170095577A1
(en)
*
|
2015-10-06 |
2017-04-06 |
Washington University |
Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
|
|
EP3368062A4
(en)
|
2015-10-30 |
2019-07-03 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT
|
|
WO2017107914A1
(zh)
*
|
2015-12-21 |
2017-06-29 |
合肥立方制药股份有限公司 |
一种药物设计方法和获得的药物及其应用
|
|
IL290457B2
(en)
|
2015-12-30 |
2025-02-01 |
Kodiak Sciences Inc |
Antibodies and their conjugates
|
|
KR20170079409A
(ko)
*
|
2015-12-30 |
2017-07-10 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 결합체의 신규 액상 제제
|
|
JP6712323B2
(ja)
|
2015-12-31 |
2020-06-17 |
ハンミ ファーマシューティカル カンパニー リミテッド |
グルカゴン、ｇｌｐ−１及びｇｉｐ受容体のすべてに活性を有する三重活性体
|
|
AU2017212739B2
(en)
|
2016-01-27 |
2024-03-21 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
AR107483A1
(es)
*
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
|
US11065306B2
(en)
|
2016-03-08 |
2021-07-20 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
US10898549B2
(en)
|
2016-04-01 |
2021-01-26 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
KR20180125979A
(ko)
|
2016-04-01 |
2018-11-26 |
알렉시온 파마슈티칼스, 인코포레이티드 |
알칼리성 포스파타아제로 근육 약화의 치료
|
|
CA3019398A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
|
JP7020403B2
(ja)
|
2016-05-02 |
2022-02-16 |
味の素株式会社 |
アジド基含有Ｆｃタンパク質
|
|
CN106008722B
(zh)
*
|
2016-05-13 |
2019-10-15 |
未名生物医药有限公司 |
一种重组β-hNGF-Fc融合蛋白、制备方法及用途
|
|
WO2017214130A1
(en)
|
2016-06-06 |
2017-12-14 |
Alexion Pharmaceuticals, Inc. |
Metal impact on manufacturing of alkaline phosphatases
|
|
CA3026420A1
(en)
|
2016-06-07 |
2017-12-14 |
Gliknik Inc. |
Cysteine-optimized stradomers
|
|
CN122440793A
(zh)
|
2016-06-29 |
2026-07-24 |
韩美药品株式会社 |
胰高血糖素衍生物、其缀合物、包含其的组合物、和其治疗用途
|
|
JP7018933B2
(ja)
|
2016-08-18 |
2022-02-14 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
気管気管支軟化症の治療方法
|
|
CN118105512A
(zh)
*
|
2016-08-30 |
2024-05-31 |
株式会社吉耐森 |
含有hGH融合蛋白的治疗生长激素缺乏症的药物组合物
|
|
AU2017332408B2
(en)
|
2016-09-23 |
2022-02-10 |
Hanmi Pharm. Co., Ltd. |
Insulin analogs with reduced affinity to insulin receptor and use thereof
|
|
JOP20190085A1
(ar)
|
2016-10-20 |
2019-04-17 |
Biogen Ma Inc |
طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة
|
|
WO2018105988A1
(ko)
*
|
2016-12-05 |
2018-06-14 |
한미약품 주식회사 |
면역반응이 약화된 결합체
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
BR112019009495A2
(pt)
|
2016-12-09 |
2019-08-06 |
Gliknik Inc |
métodos de tratamento de distúrbios inflamatórios com compostos de fc multivalentes
|
|
BR112019009484A2
(pt)
|
2016-12-09 |
2019-07-30 |
Gliknik Inc |
otimização de fabricação de gl-2045, um stradomer multimerizador
|
|
EP3578204A4
(en)
*
|
2017-02-03 |
2021-01-06 |
Hanmi Pharm. Co., Ltd. |
CONJUGATE MADE FROM BIOACTIVE MATERIAL WITH INCREASED RESISTANCE AND USE OF IT
|
|
IL268198B2
(en)
|
2017-02-27 |
2024-10-01 |
Shattuck Labs Inc |
Tigit- and light-based chimeric proteins
|
|
US11267856B2
(en)
|
2017-02-27 |
2022-03-08 |
Shattuck Labs, Inc. |
CSF1R-CD40L chimeric proteins
|
|
WO2018174668A2
(ko)
|
2017-03-23 |
2018-09-27 |
한미약품 주식회사 |
인슐린 수용체와의 결합력이 감소된 인슐린 아날로그의 결합체 및 이의 용도
|
|
KR20190129058A
(ko)
|
2017-03-31 |
2019-11-19 |
알렉시온 파마슈티칼스, 인코포레이티드 |
성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
|
|
JP2020513019A
(ja)
*
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
WO2018193033A1
(en)
*
|
2017-04-20 |
2018-10-25 |
Novo Nordisk A/S |
Methods of purification of albumin fusion proteins
|
|
ES2994451T3
(en)
|
2017-04-20 |
2025-01-24 |
Atyr Pharma Inc |
Compositions for treating lung inflammation
|
|
CN109206522B
(zh)
*
|
2017-07-07 |
2021-11-09 |
北京三有利和泽生物科技有限公司 |
一种长效抗凝血融合蛋白及其应用
|
|
WO2019066603A1
(ko)
|
2017-09-29 |
2019-04-04 |
한미약품 주식회사 |
효력이 향상된 지속성 단백질 결합체
|
|
JP6566324B2
(ja)
*
|
2017-09-29 |
2019-08-28 |
サイデン化学株式会社 |
粘着シート
|
|
BR112020005271A2
(pt)
|
2017-10-02 |
2020-09-15 |
Denali Therapeutics Inc. |
proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
|
|
KR20190045081A
(ko)
*
|
2017-10-23 |
2019-05-02 |
주식회사 프로젠 |
변형된 egf 단백질 및 이를 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물
|
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
CN108218998A
(zh)
*
|
2017-12-31 |
2018-06-29 |
武汉班科生物技术股份有限公司 |
一种突变型人源IgG的Fc片段及其制备方法与应用
|
|
KR101974305B1
(ko)
*
|
2018-02-14 |
2019-04-30 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
CA3092588A1
(en)
|
2018-03-02 |
2019-09-06 |
Kodiak Sciences Inc. |
Il-6 antibodies and fusion constructs and conjugates thereof
|
|
IL277355B2
(en)
*
|
2018-03-26 |
2025-01-01 |
Regeneron Pharma |
Humanized rodents for testing therapeutic agents
|
|
KR102209108B1
(ko)
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
|
WO2019190752A1
(en)
|
2018-03-30 |
2019-10-03 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of glycoproteins
|
|
WO2019195770A1
(en)
|
2018-04-06 |
2019-10-10 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-nrp2 antibodies
|
|
US12054527B2
(en)
|
2018-04-09 |
2024-08-06 |
Amgen Inc. |
Growth differentiation factor 15 fusion proteins
|
|
AU2019312366B2
(en)
|
2018-07-26 |
2025-08-14 |
Atyr Pharma, Inc. |
Compositions and methods for treating NRP2-associated diseases
|
|
WO2020033867A2
(en)
|
2018-08-10 |
2020-02-13 |
Alexion Pharmaceuticals, Inc. |
Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
|
|
JP2022512540A
(ja)
|
2018-08-29 |
2022-02-07 |
シャタック ラボ，インコーポレイテッド |
Ｆｌｔ３ｌ系キメラタンパク質
|
|
BR112021021271A2
(pt)
*
|
2019-04-23 |
2021-12-21 |
Lg Chemical Ltd |
Polipeptídeo de fusão compreendendo região fc de imunoglobulina e gdf15
|
|
US11267858B2
(en)
*
|
2019-05-31 |
2022-03-08 |
Spectrum Pharmaceuticals, Inc. |
Methods of treatment using G-CSF protein complex
|
|
CN112142850A
(zh)
*
|
2019-06-27 |
2020-12-29 |
深圳市卫光生物制品股份有限公司 |
人神经生长因子-乳铁蛋白重组蛋白及用途
|
|
CN114466663B
(zh)
|
2019-07-25 |
2026-01-02 |
建新公司 |
以FcRn拮抗剂治疗抗体介导的障碍的方法
|
|
AU2020358854B2
(en)
|
2019-10-03 |
2026-08-13 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-NRP2 antibodies
|
|
ES3061099T3
(en)
|
2019-10-04 |
2026-03-31 |
Amgen Inc |
Use of gdf15 for treating cardiometabolic syndrome and other conditions
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
CN110669134A
(zh)
*
|
2019-10-15 |
2020-01-10 |
广东菲鹏生物有限公司 |
IgM-FC片段、IgM-FC抗体及制备方法和应用
|
|
CA3161266A1
(en)
|
2019-12-09 |
2021-06-17 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
KR102899743B1
(ko)
*
|
2019-12-11 |
2025-12-12 |
주식회사 엘지화학 |
O-글리코실화 가능한 폴리펩타이드 영역 및 gdf15를 포함하는 융합 폴리펩타이드
|
|
CN111153996B
(zh)
*
|
2020-01-10 |
2021-12-14 |
苏州睿瀛生物技术有限公司 |
G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒
|
|
CN111505291B
(zh)
*
|
2020-04-14 |
2023-04-25 |
山东省千佛山医院 |
一种排除巨酶分子对血清酶浓度检测带来干扰的方法
|
|
AU2021276071B2
(en)
|
2020-05-22 |
2026-06-18 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation
|
|
US12611447B2
(en)
|
2020-09-04 |
2026-04-28 |
Alexion Pharmaceuticals, Inc. |
Methods for treating bone mineralization disorders
|
|
CN112098639B
(zh)
*
|
2020-09-21 |
2024-01-02 |
天津医科大学 |
以氧化石墨烯为载体的二抗的合成及应用
|
|
JP7833461B2
(ja)
*
|
2020-11-03 |
2026-03-19 |
プロタリクス リミテッド |
修飾ウリカーゼ及びその使用
|
|
AU2022218782B2
(en)
|
2021-02-12 |
2026-06-25 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
JP2024532620A
(ja)
|
2021-08-30 |
2024-09-05 |
ラッセン・セラピューティクス１・インコーポレイテッド |
抗ＩＬ－１１Ｒα抗体
|
|
MX2024008933A
(es)
*
|
2022-01-28 |
2024-09-30 |
argenx BV |
Anticuerpos anti-musk para uso en el tratamiento de trastornos neuromusculares.
|
|
EP4486758A2
(en)
*
|
2022-03-03 |
2025-01-08 |
The Trustees of the University of Pennsylvania |
Viral vectors encoding parathyroid hormone fusions and uses thereof in treating hypoparathyroidism
|
|
CN114588315A
(zh)
*
|
2022-03-14 |
2022-06-07 |
东莞市人民医院 |
抗炎蛋白涂层的制备方法、生物工程功能材料及其应用
|
|
EP4630445A2
(en)
*
|
2022-12-05 |
2025-10-15 |
Alexion Pharmaceuticals, Inc. |
Taci-fc fusion proteins for multifunctional inhibition of baff, april, and neonatal fc receptor
|
|
WO2024148240A1
(en)
|
2023-01-06 |
2024-07-11 |
Lassen Therapeutics 1, Inc. |
ANTI-IL-11Rα ANTIBODIES FOR TREATING THYROID EYE DISEASE
|
|
TW202430560A
(zh)
|
2023-01-06 |
2024-08-01 |
美商拉森醫療公司 |
抗ｉｌ－１８ｂｐ抗體
|
|
EP4646433A1
(en)
|
2023-01-06 |
2025-11-12 |
Lassen Therapeutics, Inc. |
Anti-il-18bp antibodies
|
|
US12703857B2
(en)
|
2023-02-02 |
2026-08-11 |
Protalix Ltd. |
Methods of treating diseases associated with elevated uric acid
|
|
CN121779581B
(zh)
*
|
2026-03-09 |
2026-06-16 |
华中农业大学 |
长效猫粒细胞巨噬细胞集落刺激因子重组蛋白、及其cho细胞表达方法和应用
|